Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recognition of Self and Viral Ligands by NK Cell Receptors. | Immunol Rev | 2025 | 39748148 | PubTator, text mining | PubMed |
| Intra- and Extrahepatic Cholangiocarcinomas Display Differing Sensitivities to NK Cell Lysis and Modulate NK Cell Function through Shared and Distinct Pathways. | Mol Cancer Res | 2025 | 39436670 | PubTator, text mining | PubMed |
| Transcriptional signature of CD56bright NK cells predicts favourable prognosis in bladder cancer. | Front Immunol | 2024 | 39877370 | PubTator, text mining | PubMed |
| Analysis of the Blood Levels of NK and NKT Cells in Patients with Severe SARS-CoV-2 Infection. | Iran J Immunol | 2024 | 39624905 | PubTator, text mining | PubMed |
| Exercise: a non-drug strategy of NK cell activation. | Braz J Med Biol Res | 2024 | 39607207 | PubTator, text mining | PubMed |
| Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia. | Ann Hematol | 2024 | 39505795 | PubTator, text mining | PubMed |
| Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response. | Nat Commun | 2024 | 39438480 | PubTator, text mining | PubMed |
| Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition. | Front Immunol | 2024 | 39301032 | PubTator, text mining | PubMed |
| Ligand requirements for immunoreceptor triggering. | Commun Biol | 2024 | 39271744 | PubTator, text mining | PubMed |
| A scalable, spin-free approach to generate enhanced induced pluripotent stem cell-derived natural killer cells for cancer immunotherapy. | Immunol Cell Biol | 2024 | 39269338 | PubTator, text mining | PubMed |
| An organotypic human melanoma-in-skin model as an in vitro tool for testing Vγ9Vδ2-T cell-based immunotherapy. | Immunooncol Technol | 2024 | 39220726 | PubTator, text mining | PubMed |
| Raddeanin A augments the cytotoxicity of natural killer cells against chronic myeloid leukaemia cells by modulating MAPK and Ras/Raf signalling pathways. | J Cell Mol Med | 2024 | 39175122 | PubTator, text mining | PubMed |
More balance toward activating receptors and cytotoxic activity of NK cells ex vivo differentiated from human umbilical cord blood-derived CD34+ stem cells in comparison with peripheral blood NK cells. | Heliyon | 2024 | 39170467 | PubTator, text mining | PubMed |
| A comprehensive model to better screen out antiviral treatment candidates for chronic hepatitis B patients. | Int Immunopharmacol | 2024 | 39096876 | PubTator, text mining | PubMed |
| Circulating innate lymphoid cells (cILCs): Unconventional lymphocytes with hidden talents. | J Allergy Clin Immunol | 2024 | 39046403 | PubTator, text mining | PubMed |
| TLR Agonists Modify NK Cell Activation and Increase Its Cytotoxicity in Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2024 | 39000607 | PubTator, text mining | PubMed |
| O-GlcNAcylation and immune cell signaling: A review of known and a preview of unknown. | J Biol Chem | 2024 | 38718861 | PubTator, text mining | PubMed |
| Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance. | Front Immunol | 2024 | 38698854 | PubTator, text mining | PubMed |
| Natural killer cell subsets and their functional molecules in peripheral blood of the patients with breast cancer. | Immun Inflamm Dis | 2024 | 38652012 | PubTator, text mining | PubMed |
| NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells. | Cell Rep | 2024 | 38615318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers?page=5